Differences in Existential Perspectives as a Function of Having a Mystical-Type Experience
Alex Sielaff, Dylan E. Horner, Jeff Greenberg
Journal of Humanistic Psychology March 9, 2023 DOI: 10.1177/00221678231158679 (opens in new tab) via OpenAlex
Summary
AI-generated from the abstractPeople who have had mystical-type experiences (MTEs) report less fear of death, greater belief in death as a passage, a more intrinsic and growth-oriented worldview, and higher trait absorption compared to those who have not. However, contrary to expectations based on clinical psychedelic research, they also report more mental health symptoms. This suggests that MTEs occurring outside a supportive therapeutic context may not produce the same psychological benefits seen in clinical settings.
Study at a glance
| Characteristics | Cross-sectional study Peer reviewed |
|---|---|
| Sample size | 1,923 |
| Population | Adults who have or have not had mystical-type experiences |
| Topics | Anxiety Mysticism |
| Keywords | Existentialism Trait Context archaeology Death anxiety |
| Citations | 3 |
| Key finding | MTEs are associated with less death anxiety and more growth-oriented worldviews but also with more mental health symptoms, contrary to clinical findings. |
Abstract
Prior research suggests that unique phenomenological experiences called “mystical-type experiences” (MTEs) have the potential to induce significant and persisting worldview changes. In this article, two studies add to this literature by using cross-sectional data from 837 and 1,086 participants, respectively, to investigate whether people who have had one of these experiences differ in predictable ways from those who have not on relevant existential variables. Specifically, we tested two novel hypotheses rooted in terror management theory, along with two predictions based on past research. In specific, the yes-MTE group was hypothesized to have (a) less fear of death and greater belief in death as a passage, (b) a more intrinsic and growth-oriented worldview, (c) fewer mental health symptoms, and (d) higher trait absorption. The data largely supported hypotheses 1, 2, and 4 while the results for hypothesis 3 were opposite of expectations, suggesting that clinical research with psychedelic-induced MTEs may not be generalizable to MTEs experienced outside the supportive therapeutic context.